Charles S. Berkman, VP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 7,166 shares at $66.93 ($479K) on 2014-05-27, disclosed to the SEC on 2014-05-28.
Open-market sale of $479k LGND by VP, General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.89 | 4,667 | $312K | 65.1% |
| 2 | $66.93 | 347 | $23K | 4.8% |
| 3 | $66.93 | 486 | $33K | 6.8% |
| 4 | $66.93 | 1,666 | $112K | 23.3% |
| Total | $66.90 avg | 7,166 | $479K | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |